cd1a-car t
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 31, 2023 (NCT05679895)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Antigen-presenting glycoprotein CD1dImmunity, passive
CD1D immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05679895 | Phase 1 | Jan 31, 2023 | BioClever 2005 S.L., OneChain Immunotherapeutics, University of Barcelona |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BioClever 2005 S.L. | For profit | 1 | 0 | 1 | 2023 |
| OneChain Immunotherapeutics | For profit | 1 | 1 | 1 | 2023 |
| University of Barcelona | Academic/Hospital | 1 | 0 | 1 | 2023 |
3 organizations
Page 1 / 1